Fresenius Kabi
↗Bad Homburg, Germany
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company's products and services are used to help care for critically and chronically ill patients. Its product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies, and clinical nutrition products as well as the devices for administering these products.
In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the company launched its first biosimilar product, followed by a rapidly expanding pipeline. The company also provides medical devices and products for transfusion medicine and cell therapies. Fresenius Kabi is a key business segment of the German healthcare group Fresenius SE & Co. KGaA.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics, Biosimilars, and Medical Devices
SIZE & FINANCIALS
Employees:10000+
Revenue:$8B-$9B
Founded:1999
Ownership:subsidiary
Status:operating
FUNDING
Stage:Public
STOCK
Exchange:Frankfurt Stock Exchange (Parent: FRE)
Ticker:FRE
Market Cap:$18B (Parent Company)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb (Biosimilars), Infusion Technology, Parenteral Nutrition
Active Trials:36
Trial Phases:Phase 1: 12 | Phase 2: 4 | Phase 3: 8 | Phase 4: 2
FDA Approvals:6
EMA Approvals:5
CORPORATE STRUCTURE
Parent Company:Fresenius SE & Co. KGaA
Subsidiaries:Fresenius Kabi USA, LLC, mAbxience (Majority Stake), Ivenix, Inc., Fenwal, Inc.
Key Partnerships:Formycon (Biosimilar development), mAbxience (Biologics manufacturing)
COMPETITION
Position:Leader
Competitors:Sandoz, Pfizer (Hospira), Viatris, Baxter International, B. Braun Melsungen
LEADERSHIP
Key Executives:
Pierluigi Antonelli - CEO
Arunesh Verma - President, Region U.S.
Dr. Sang-Jin Pak - President Biopharma
Board Members:Michael Sen (Chairman of the Supervisory Board), Sara Hennicken
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fresenius Kabi. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.